PCN30 COST-EFFECTIVENESS OF APREPITANT IN PATINENTS RECEIVING ANTIEMETIC PROPHYLAXIS FOR HIGHLY EMETOGENIC CHEMOTHERAPY IN HUNGARY
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66567-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)66567-9/fulltext
Title :
PCN30 COST-EFFECTIVENESS OF APREPITANT IN PATINENTS RECEIVING ANTIEMETIC PROPHYLAXIS FOR HIGHLY EMETOGENIC CHEMOTHERAPY IN HUNGARY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66567-9&doi=10.1016/S1098-3015(10)66567-9
First page :
Section Title :
Open access? :
No
Section Order :
402